-
Je něco špatně v tomto záznamu ?
Chemoresistance testing of human ovarian cancer cells and its in vitro model
K Brigulova, M Cervinka, J Tosner, I Sedlakova
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu práce podpořená grantem
Grantová podpora
NS9737
MZ0
CEP - Centrální evidence projektů
- MeSH
- biologické modely MeSH
- chemorezistence * MeSH
- cisplatina toxicita MeSH
- deoxycytidin analogy a deriváty toxicita MeSH
- etoposid toxicita MeSH
- karboplatina toxicita MeSH
- karcinom * farmakoterapie MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nádory vaječníků * farmakoterapie MeSH
- paclitaxel toxicita MeSH
- protinádorové látky toxicita MeSH
- screeningové testy protinádorových léčiv MeSH
- topotekan toxicita MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
Ovarian carcinoma represents the most common cause of death from gynecological malignancies in Europe and North America, being the third most frequent and the first as to the mortality. The standard chemotherapeutical regimen for ovarian cancer involves the administration of platinum derivate (carboplatin, cisplatin), in advanced stage is platinum derivate combined with paclitaxel. Introducing chemoresistance testing of ovarian tumour cells may help to choose optimal chemotherapeutic drug and customize the individual chemotherapeutical regimens in patients. One of approaches of individualization of chemotherapy is in vitro chemosensitivity testing. In our study, we evaluated the cytotoxic effects of selected chemotherapeutics in cells isolated from ovarian tumours and ascites of individual patients. Panel of chemotherapeutics used in the study included cisplatin, paclitaxel, carboplatin, topotecan, gemcitabine and etoposide and their effects on cell viability were determined by the MTT assay. In the total number of 32 clinical samples of tumour and ascites cells, the highest sensitivity showed cells to topotecan, sensitivity to cisplatin was higher than to carboplatin and paclitaxel used in clinical practice showed most often only the marginal reactivity. Resistance to carboplatin and most of the time to gemcitabine and etoposide was commonly present. When the same test on cells that have been frozen for several weeks was repeated it was found that in 20 cases chemosensitivity increased while in 18 cases decreased. In remaining cases there was no change in reactivity to cytostatics. Moreover, chemosensitivity of cells isolated from solid tumour and ascites from the same patient did not show any significant difference with exaption of paclitaxel. Copyright 2010 Elsevier Ltd. All rights reserved.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14050293
- 003
- CZ-PrNML
- 005
- 20140331090803.0
- 007
- ta
- 008
- 140328s2010 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.tiv.2010.08.010 $2 doi
- 035 __
- $a (PubMed)20736059
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Caltová, Kateřina $7 xx0197111 $u Department of Medical Biology and Genetics Faculty of Medicine in Hradec Kralove, Charles University in Prague, Czech Republic. brigulovak@lfhk.cuni.cz
- 245 10
- $a Chemoresistance testing of human ovarian cancer cells and its in vitro model / $c K Brigulova, M Cervinka, J Tosner, I Sedlakova
- 520 9_
- $a Ovarian carcinoma represents the most common cause of death from gynecological malignancies in Europe and North America, being the third most frequent and the first as to the mortality. The standard chemotherapeutical regimen for ovarian cancer involves the administration of platinum derivate (carboplatin, cisplatin), in advanced stage is platinum derivate combined with paclitaxel. Introducing chemoresistance testing of ovarian tumour cells may help to choose optimal chemotherapeutic drug and customize the individual chemotherapeutical regimens in patients. One of approaches of individualization of chemotherapy is in vitro chemosensitivity testing. In our study, we evaluated the cytotoxic effects of selected chemotherapeutics in cells isolated from ovarian tumours and ascites of individual patients. Panel of chemotherapeutics used in the study included cisplatin, paclitaxel, carboplatin, topotecan, gemcitabine and etoposide and their effects on cell viability were determined by the MTT assay. In the total number of 32 clinical samples of tumour and ascites cells, the highest sensitivity showed cells to topotecan, sensitivity to cisplatin was higher than to carboplatin and paclitaxel used in clinical practice showed most often only the marginal reactivity. Resistance to carboplatin and most of the time to gemcitabine and etoposide was commonly present. When the same test on cells that have been frozen for several weeks was repeated it was found that in 20 cases chemosensitivity increased while in 18 cases decreased. In remaining cases there was no change in reactivity to cytostatics. Moreover, chemosensitivity of cells isolated from solid tumour and ascites from the same patient did not show any significant difference with exaption of paclitaxel. Copyright 2010 Elsevier Ltd. All rights reserved.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a protinádorové látky $x toxicita $7 D000970
- 650 02
- $a karboplatina $x toxicita $7 D016190
- 650 12
- $a karcinom $x farmakoterapie $7 D002277
- 650 02
- $a nádorové buněčné linie $7 D045744
- 650 02
- $a cisplatina $x toxicita $7 D002945
- 650 02
- $a deoxycytidin $x analogy a deriváty $x toxicita $7 D003841
- 650 12
- $a chemorezistence $7 D019008
- 650 02
- $a screeningové testy protinádorových léčiv $7 D004354
- 650 02
- $a etoposid $x toxicita $7 D005047
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a lidé $7 D006801
- 650 02
- $a biologické modely $7 D008954
- 650 12
- $a nádory vaječníků $x farmakoterapie $7 D010051
- 650 02
- $a paclitaxel $x toxicita $7 D017239
- 650 02
- $a topotekan $x toxicita $7 D019772
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Červinka, Miroslav, $d 1950- $7 nlk19990074194 $u Department of Medical Biology and Genetics Faculty of Medicine in Hradec Kralove, Charles University in Prague, Czech Republic
- 700 1_
- $a Tošner, Jindřich, $d 1947- $7 jn19990209929 $u Department of Gynecology and Obsterics Faculty of Medicine in Hradec Kralove, Charles University in Prague, Czech Republic
- 700 1_
- $a Sedláková, Iva $7 xx0061816 $u Department of Gynecology and Obsterics Faculty of Medicine in Hradec Kralove, Charles University in Prague, Czech Republic
- 773 0_
- $t Toxicology in Vitro $g Roč. 24, č. 8 (2010), s. 2108-2115 $p Toxicol In Vitro $x 0887-2333 $w MED00004536
- 910 __
- $a ABA008 $y 4 $z 0
- 990 __
- $a 20140328113704 $b ABA008
- 991 __
- $a 20140331090841 $b ABA008
- 999 __
- $a ok $b bmc $g 1017478 $s 848867
- BAS __
- $a 3
- BMC __
- $a 2010 $b 24 $c 8 $d 2108-2115 $x MED00004536 $i 0887-2333 $m Toxicology in vitro $n Toxicol In Vitro
- GRA __
- $a NS9737 $p MZ0
- LZP __
- $a NLK 2014-03/lpbo
